Form 4 for IDXX Idexx Laboratories
Accepted 2022-02-25 00:00:00 ET · period of report 2022-02-23 · accession 0001567619-22-005670 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-25 | 2022-02-23 | IDXX | TWIGGE GIOVANI | SVP | M - OptEx | $248.80 | +2,599 | 18.4K | +16% | +$646.6K |
| DM | 2022-02-25 | 2022-02-23 | IDXX | TWIGGE GIOVANI | SVP | M - OptEx | — | -2,599 | 3,784 | -41% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-23 | M | A | 1,893 | $288.78 | 20,329.48 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-23 | M | A | 706 | $141.60 | 18,436.48 | D | — | — | |
| 3 | Derivative | Incentive Stock Option (right-to-buy) | 2022-02-23 | M | D | 706 | — | 0 | D | $141.60 · — to 2027-02-13 | 706 Common Stock | (F3) Not applicable. (F1) Grant of option to buy 706 shares of Issuer common stock that vested in one installment on February 14, 2022. |
| 4 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2022-02-23 | M | D | 1,893 | — | 3,784 | D | $288.78 · — to 2030-02-13 | 1,893 Common Stock | (F3) Not applicable. (F2) Grant of option to buy 7,570 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021. |